BOVILIS® 20/20 VISION® 7 WITH SPUR®*
Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Moraxella Bovis Bacterin-Toxoid
Product Description
Offers powerful protection against pinkeye, blackleg and more.
Blackleg prevention is critical. But that’s not the only thing calves need protection from. BOVILIS 20/20 VISION 7 WITH SPUR is a comprehensive option that is effective against pinkeye, as well a number of other concerning clostridial diseases. It also contains the proprietary SPUR adjuvant, which results in fewer reactions and reduced stress on cattle post-vaccination.1-2
Indications
This product has been shown effective for the vaccination of healthy cattle against Clostridium chauvoei, C. septicum, C. novyi, C. sordellii,
C. perfringens Type C & D, and Moraxella bovis.
Diseases
- C. sordellii
The SPUR adjuvant utilized in BOVILIS 20/20 VISION 7 WITH SPUR allows for the highest level of immunization with the lowest level of injection site reactions.1,2
A Game-changing Vaccine
Understanding immunology and innovation are critical to addressing emerging diseases and industry challenges through new and improved vaccines. Merck Animal Health has a history of finding a better way forward through vaccine advancements, and today offers one of the most complete vaccine portfolios. Learn about BOVILIS VISION from members of the team who brought it to market.
Dosage
Shake well and administer a single 2 mL dose aseptically by subcutaneous route. Repeat the dose in 3 – 4 weeks. For advice on revaccination frequency, contact your veterinarian.
Supplied
1 x 20mL (10 doses)
1 x 100mL (50 doses)
Preservatives
Contains formaldehyde and polymyxin B as preservatives.
Storage
Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened.
Contact
U.S. only: Merck Animal Health livestocktechsrvc@merck-animal-health.com or call 1-800-211-3573
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov
For additional information, please see the product label.
Important Safety Information
Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. If allergic reaction occurs, treat with epinephrine. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY.
References
*Adjuvant-Intervet’s Proprietary Technology.
- Technical Reference 96-4: Evaluation of Injection-Site Blemishes Using Ultrasonography Following Administration of Two Commercial Multivalent Clostridial Vaccines.
- Technical Reference 96-2: Analysis of Post-Vaccinal Injection Sites Using Ultrasound.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global